Chemoprotective effect of Phyllanthus maderaspatensis in modulating cisplatin-induced nephrotoxicity and genotoxicity

Pharmaceutical Biology

Volumn 44, Issue 2, 2006, Pages 100-106

  Chandrasekar, M J N ^a   Bommu, Praveen ^b   Nanjan, M J ^b   Suresh, B ^b  

^a Department of Pharmaceutical Chemistry ^*

^b JSS COLLEGE OF PHARMACY   (India)

Author keywords

Antioxidants; Chemoprotection; Cisplatin; Genotoxicity; Nephrotoxicity; Phyllanthus maderaspatensis

Indexed keywords

CISPLATIN; CREATININE; PHYLLANTHUS MADERASPATENSIS EXTRACT; PLANT EXTRACT; SCAVENGER; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; GENOTOXICITY; KIDNEY DYSFUNCTION; KIDNEY MASS; MALE; MICRONUCLEUS TEST; MOUSE; MULTINUCLEAR CELL; NEPHROTOXICITY; NONHUMAN; PHYLLANTHUS; RENAL PROTECTION; SINGLE DRUG DOSE; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; TISSUE SECTION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALIA; PHYLLANTHUS MADERASPATENSIS;

EID: 33645049569     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200600592046     Document Type: Article

References (37)

1. Asha VV, Pushpangadan P (1998): Preliminary evaluation of the antihepatotoxic activity of Phyllanthus kozhikodianus, Phyllanthus maderspatensis and Solanum indicum. Fitoterapia 59: 255-259.
2. Asha VV, Akhila S, Wills PJ, Subramoniam A (2004): Further studies on the antihepatotoxic activity of Phyllanthus maderaspatensis Linn. J Ethnopharmacol 92: 67-70.
3. Chu G (1994): Cellular responses to cisplatin. J Biol Chem 269: 787-790.
4. Devipriya S, Shyamaladevi CS (1999): Protective effect of quercetin in cisplatin induced cell injury in the rat kidney. Indian J Pharmacol 31: 422.
5. Fantone JC, Ward PA (1982): Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107: 395-418.
6. Fogliano V, Verde V, Randazzo G, Ritieni A (1999): Method for measuring antioxidant capacity of wines. J Agric Food Chem 47: 1035-1040.
7. Fox RB (1984): Prevention of granulocyte-mediated oxidative injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J Clin Invest 74: 1456-1464.
8. Harborne JB (1984): Phytochemical Methods. New York, Chapman and Hall, pp. 123-175.
9. IARC Monographs on the Evaluation of Carcinogenic Risks to Human: (1987): In: Overall Evaluation of Carcinogenicity, Vol. 42. Lyon, France, International Agency for Research on Cancer.
10. Jagetia GC, Jacob PS (1992): Vinblastine treatment induces dose-dependent increases in the frequency of micronuclei in mouse bone marrow. Mutat Res 280: 87-92.
11. Kirthikar KR, Basu BD (1999): In: Blatter E, Calus JF, Mhaskar KS, eds., Indian Medicinal Plants. Dehradun, India, International Book Distributors, pp. 2222-2223.
12. Kociba RJ, Sleight SD, Rosenberg B (1970): Inhibition of Dunning ascitic leukemia and Walker-256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875). Cancer Chemother Rep 54: 325-328.
13. Li Q, Bowmer CJ, Yates MS (1995): Amelioration of cisplatin nephrotoxicity with glycine: Dose dependency in rats. J Pharm Pharmacol 47: 223-226.
14. Loehrer PJ, Einhorn LH (1984): Drugs five years later. Cisplatin. Ann Intern Med 100: 704-713.
15. Masuda H, Tanaka T, Takahama U (1994): Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203: 1175-1180.
16. Moure A, Franco D, Sineiro J, Dominguez H, Nunez MJ, Lema JM (2000): Evaluation of extracts from Gevuina avellana hulls as antioxidants. J Agric Food Chem 48: 3890-3897.
17. Pinto AL, Lippard SJ (1985): Binding of the antitumor drug, cis-diamminedichloroplatinum II cisplatin to DNA. Biochim Biophys Acta 780: 167-180.
18. Prasad SB, Giri A (1994): Antitumor effect of cisplatin against murine ascites Dalton's lymphoma. Indian J Exp Biol 32: 57-62.
19. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham IB (1995): The relative antioxidant activities of plant-derived polyphenolic flavanoids. Free Radic Res 22: 375-383.
20. Rosenberg B (1985). Fundamental studies with cisplatin. Cancer 55: 2303-2316.
21. Schmidt W (1975). The micronucleus test. Mutat Res 31: 9-15.
22. Sdzuka Y, Shoji T, Takino Y (1992): Effect of cisplatin on the activation of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43: 1872-1875.
23. Shah SV (1984): Effect of enzymatically generated reactive oxygen metabolites on the cyclic nucleotide content in isolated glomeruli. J Clin Invest 74: 393-401.
24. Shah SV, Barcos WH, Basci A (1987): Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase by reactive oxygen metabolite. J Clin Invest 79: 25-31.
25. Sharma S, Stutzman JD, Kelloff GJ, Steele VE (1994): Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 54: 5848-5855.
26. Sokmen A, Jones BM, Erturk M (1999): The in vitro antibacterial activity of Turkish medicinal plants. J Ethnopharmacol 67: 79-86.
27. Sorsa M, Hemminki K, Vainio H (1985): Occupational exposure to anti-cancer drugs: potential and hazard. Mutat Res 154: 135-149.
28. Surh YJ (1999): Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428: 305-327.
29. Thyagarajan SP, Subramanian S, Thirunalasundari T, Venkateswaran PS, Blumberg BS (1988): Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 2: 764-766.
30. Unander DW, Venkateswaran PS, Millman I, Bryan HH, Blumberg BS (1990): Phyllanthus species: Source of new antiviral compounds. In: Janick J, Simon JE, eds., Advances in New Crops. Portland, Timber Press, pp. 518-521.
31. Unander DW, Webster GL, Blumberg BS (1995): Usage and bioassays in phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J Ethnopharmacol 45: 1-18.
32. Varani J, Fligiel SE, Till GO, Kunkel RG, Ryan US, Ward PA (1985): Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Lab Invest 53: 656-663.
33. Wattenberg LW (1985): Chemoprevention of cancer. Cancer Res 45: 1-8.
34. Weijl NI, Cleton FJ, Osanto S (1997): Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23: 209-240.
35. Weiss SJ, LoBuglio AF (1982): Phagocyte-generated oxygen metabolites and cell injury. Lab Invest 47: 5-18.
36. Zamble DB, Lippard SJ (1995): Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20: 435-439.
37. Zhang JG, Lindup WE (1994): Cisplatin nephrotoxicity: Decreases in mitochondrial protein sulfhydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol 47: 1127-1135.